296 related articles for article (PubMed ID: 31085163)
1. Emerging strategies to disrupt the central TGF-β axis in kidney fibrosis.
Rauchman M; Griggs D
Transl Res; 2019 Jul; 209():90-104. PubMed ID: 31085163
[TBL] [Abstract][Full Text] [Related]
2. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment.
Chen L; Yang T; Lu DW; Zhao H; Feng YL; Chen H; Chen DQ; Vaziri ND; Zhao YY
Biomed Pharmacother; 2018 May; 101():670-681. PubMed ID: 29518614
[TBL] [Abstract][Full Text] [Related]
3. TGF-β signaling in the kidney: profibrotic and protective effects.
Sureshbabu A; Muhsin SA; Choi ME
Am J Physiol Renal Physiol; 2016 Apr; 310(7):F596-F606. PubMed ID: 26739888
[TBL] [Abstract][Full Text] [Related]
4. Targeting TGF-β Signaling in Kidney Fibrosis.
Isaka Y
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30150520
[TBL] [Abstract][Full Text] [Related]
5. TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?
Muñoz-Félix JM; González-Núñez M; Martínez-Salgado C; López-Novoa JM
Pharmacol Ther; 2015 Dec; 156():44-58. PubMed ID: 26493350
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor β (TGFβ) and related molecules in chronic kidney disease (CKD).
Huynh P; Chai Z
Clin Sci (Lond); 2019 Jan; 133(2):287-313. PubMed ID: 30683713
[TBL] [Abstract][Full Text] [Related]
7. TGF-β/Smad and Renal Fibrosis.
Ma TT; Meng XM
Adv Exp Med Biol; 2019; 1165():347-364. PubMed ID: 31399973
[TBL] [Abstract][Full Text] [Related]
8. Leptin is a coactivator of TGF-beta in unilateral ureteral obstructive kidney disease.
Kümpers P; Gueler F; Rong S; Mengel M; Tossidou I; Peters I; Haller H; Schiffer M
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1355-62. PubMed ID: 17686962
[TBL] [Abstract][Full Text] [Related]
9. TGFβ-incurred epigenetic aberrations of miRNA and DNA methyltransferase suppress Klotho and potentiate renal fibrosis.
Yin S; Zhang Q; Yang J; Lin W; Li Y; Chen F; Cao W
Biochim Biophys Acta Mol Cell Res; 2017 Jul; 1864(7):1207-1216. PubMed ID: 28285987
[TBL] [Abstract][Full Text] [Related]
10. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta and Smad signalling in kidney diseases.
Wang W; Koka V; Lan HY
Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
[TBL] [Abstract][Full Text] [Related]
12. SREBP inhibition ameliorates renal injury after unilateral ureteral obstruction.
Mustafa M; Wang TN; Chen X; Gao B; Krepinsky JC
Am J Physiol Renal Physiol; 2016 Sep; 311(3):F614-25. PubMed ID: 27385736
[TBL] [Abstract][Full Text] [Related]
13. Organ fibrosis inhibited by blocking transforming growth factor-β signaling via peroxisome proliferator-activated receptor γ agonists.
Deng YL; Xiong XZ; Cheng NS
Hepatobiliary Pancreat Dis Int; 2012 Oct; 11(5):467-78. PubMed ID: 23060391
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E ameliorates renal fibrosis by inhibition of TGF-beta/Smad2/3 signaling pathway in UUO mice.
Tasanarong A; Kongkham S; Duangchana S; Thitiarchakul S; Eiam-Ong S
J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S1-9. PubMed ID: 22619900
[TBL] [Abstract][Full Text] [Related]
15. Contribution of genetics and epigenetics to progression of kidney fibrosis.
Tampe B; Zeisberg M
Nephrol Dial Transplant; 2014 Sep; 29 Suppl 4():iv72-9. PubMed ID: 23975750
[TBL] [Abstract][Full Text] [Related]
16. Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases.
Shi N; Wang Z; Zhu H; Liu W; Zhao M; Jiang X; Zhao J; Ren C; Zhang Y; Luo L
Immunol Res; 2022 Jun; 70(3):276-288. PubMed ID: 35147920
[TBL] [Abstract][Full Text] [Related]
17. [Transforming growth factor-β and renal fibrosis].
Meng XM; Lan HY
Sheng Li Xue Bao; 2018 Dec; 70(6):612-622. PubMed ID: 30560270
[TBL] [Abstract][Full Text] [Related]
18. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
[TBL] [Abstract][Full Text] [Related]
20. The many talents of transforming growth factor-β in the kidney.
Gewin L
Curr Opin Nephrol Hypertens; 2019 May; 28(3):203-210. PubMed ID: 30893214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
